1. Home
  2. MEG vs CGEM Comparison

MEG vs CGEM Comparison

Compare MEG & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Montrose Environmental Group Inc.

MEG

Montrose Environmental Group Inc.

HOLD

Current Price

$20.81

Market Cap

846.0M

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$11.59

Market Cap

780.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEG
CGEM
Founded
2012
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
846.0M
780.4M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
MEG
CGEM
Price
$20.81
$11.59
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$33.50
$28.33
AVG Volume (30 Days)
316.1K
681.3K
Earning Date
02-25-2026
03-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$826,323,000.00
N/A
Revenue This Year
$19.70
N/A
Revenue Next Year
$2.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.77
N/A
52 Week Low
$10.51
$5.68
52 Week High
$32.00
$13.43

Technical Indicators

Market Signals
Indicator
MEG
CGEM
Relative Strength Index (RSI) 38.73 52.36
Support Level $21.92 $11.36
Resistance Level $25.48 $12.55
Average True Range (ATR) 1.06 0.86
MACD 0.01 -0.11
Stochastic Oscillator 8.65 26.81

Price Performance

Historical Comparison
MEG
CGEM

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: